Novel joint selection methods can reduce sample size for rheumatoid arthritis clinical trials with ultrasound endpoints.

Our pilot study suggests that sample size for RA clinical trials with ultrasound endpoints may be reduced using the novel methods, providing justification for larger studies to confirm these observations.